Liminatus Pharma Competitors and Similar CompaniesClear all

Liminatus Pharma's competitors and similar companies include CEL-SCI and SingletO2 Therapeutics.

	Liminatus Pharma Liminatus Pharma (formerly known as Iris Acquisition) is a pre‑clinical‑stage immuno‑oncology company.	CEL-SCI CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.	SingletO2 Therapeutics SingletO2 Therapeutics is a company engaged in developing treatments for periodontal disease.
Founding Date	Founding Date 2018	Founding Date 1983	Founding Date 2015
Type	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech clinical research drug development therapy	Tags Healthcare biotech clinical research drug development therapy	Tags Healthcare biotech clinical research drug development therapy
Locations	Locations La Palma, US HQ	Locations Vienna, US HQ	Locations Summit, US HQ
Employees	Employees 1	Employees N/A	Employees 2
Financial
Net income	Net income ($10.2m) (FY, 2025)	Net income ($25.4m) (FY, 2025)	Net income N/A

For sources of this data, please see the company profile

Vienna, US

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.

Summit, US

Employees

SingletO2 Therapeutics is a company engaged in developing treatments for periodontal disease.

Financial